WallStreetZenWallStreetZen

NASDAQ: GERN
Geron Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GERN stock forecasts and price targets.

Forecast return on equity

Is GERN forecast to generate an efficient return?

Company
98.35%
Industry
73.62%
Market
159.32%
GERN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GERN forecast to generate an efficient return on assets?

Company
38.94%
Industry
30.74%
GERN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GERN earnings per share forecast

What is GERN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.04
Avg 2 year Forecast
$0.03
Avg 3 year Forecast
$0.05

GERN revenue forecast

What is GERN's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$235.4M+28%
Avg 2 year Forecast
$336.1M+82.8%
Avg 3 year Forecast
$486.9M+164.76%
GERN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GERN revenue growth forecast

How is GERN forecast to perform vs Biotechnology companies and vs the US market?

Company
37.46%
Industry
35.65%
Market
14.13%
GERN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GERN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GERN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GERN$1.58N/AN/A
MRVI$3.94$4.50+14.21%Strong Buy
PHAT$12.67$21.50+69.69%Strong Buy
IVA$5.40$13.20+144.44%Strong Buy
SANA$3.64$7.00+92.31%Buy
View Top Biotech Stocks

Geron Stock Forecast FAQ

What is GERN's earnings growth forecast for 2026-2028?

(NASDAQ: GERN) Geron's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.74%.

Geron's earnings in 2026 is -$83,500,000.On average, 8 Wall Street analysts forecast GERN's earnings for 2026 to be -$27,223,148, with the lowest GERN earnings forecast at -$43,941,364, and the highest GERN earnings forecast at -$13,451,438. On average, 8 Wall Street analysts forecast GERN's earnings for 2027 to be $21,778,518, with the lowest GERN earnings forecast at -$50,218,701, and the highest GERN earnings forecast at $107,611,503.

In 2028, GERN is forecast to generate $32,667,778 in earnings, with the lowest earnings forecast at -$31,386,688 and the highest earnings forecast at $100,885,784.

If you're new to stock investing, here's how to buy Geron stock.

What is GERN's revenue growth forecast for 2026-2028?

(NASDAQ: GERN) Geron's forecast annual revenue growth rate of 37.46% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Geron's revenue in 2026 is $183,881,000.On average, 8 Wall Street analysts forecast GERN's revenue for 2026 to be $150,764,996,860, with the lowest GERN revenue forecast at $141,176,043,284, and the highest GERN revenue forecast at $161,577,390,737. On average, 8 Wall Street analysts forecast GERN's revenue for 2027 to be $215,306,276,902, with the lowest GERN revenue forecast at $183,426,369,124, and the highest GERN revenue forecast at $279,828,340,604.

In 2028, GERN is forecast to generate $311,849,168,208 in revenue, with the lowest revenue forecast at $231,588,922,185 and the highest revenue forecast at $505,684,388,073.

What is GERN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GERN) forecast ROA is 38.94%, which is higher than the forecast US Biotechnology industry average of 30.74%.

What is GERN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GERN) Geron's current Earnings Per Share (EPS) is -$0.13. On average, analysts forecast that GERN's EPS will be -$0.04 for 2026, with the lowest EPS forecast at -$0.07, and the highest EPS forecast at -$0.02. On average, analysts forecast that GERN's EPS will be $0.03 for 2027, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at $0.17. In 2028, GERN's EPS is forecast to hit $0.05 (min: -$0.05, max: $0.16).

What is GERN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GERN) forecast ROE is 98.35%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.